ALPHARMA Inc. (ALO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

440 ROUTE 22 BRIDGEWATER, NJ 08807

Develops, makes, and sells specialty generic and proprietary human pharmaceutical and animal pharmaceutical products. Product formulations include solid, liquid, topical, ointments, creams, suppositories and injections.

Data based on most recent fiscal year report
Market Cap1.543 Billion Shares Outstanding41.764 Million Avg Volume2.316 Million
1-Yr BETA vs S&P TR Current Ratio2.93 Quick Ratio2.3

Are you looking for these stocks instead?

View SEC Filings from ALO instead.
Q2 2019 All Institutions Hedge Funds 1
To trade ALO now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 1 0 (0.0%)
Aggregate 13F shares on 06/30/2019: 1 0
Aggregate 13F shares on 03/31/2019: 0
Percent change:
Funds creating new positions: 1
Funds Adding to an existing position:
Funds closing out their position:
Funds reducing their position:
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MITCHELL DEAN J

  • Director
0 2019-09-30 0

UPRICHARD DAVID C

  • Director
0 2019-05-29 0

JPMORGAN CHASE & CO

  • 10% Owner
49,940,222 2018-12-05 0

WRENN CAROL

  • Director
5,249 2018-05-03 0

SHIVELY RICHARD SCOTT SVP & CHIEF COMMERCIAL OFFICER

  • Officer
4,290 2016-04-02 0

BUZINKAI DONALD CHIEF ACCOUNTING OFFICER

  • Officer
7,129 2010-02-23 0

CAMPBELL JEFFREY SEE REMARKS

  • Officer
No longer subject to file 2008-12-29 0

WARNER RONALD EXECVP & CHIEF SCIENTIFIC OFC

  • Officer
No longer subject to file 2008-12-29 0

WATTS PETER EVP, HR AND COMMUNICATIONS

  • Officer
No longer subject to file 2008-12-29 0

SPELLMAN THOMAS J III EXEC VP, GEN COUNSEL & SEC

  • Officer
No longer subject to file 2008-12-29 0

TOMBROS PETER

  • Director
No longer subject to file 2008-12-29 0

PEREZ RAY

  • Director
No longer subject to file 2008-12-29 0

JACOBSEN FINN BERG

  • Director
No longer subject to file 2008-12-29 0

PETER LADELL W

  • Director
No longer subject to file 2008-12-29 0

DEL BUONO JOSEPH SEE REMARKS

  • Officer
No longer subject to file 2008-12-29 0

J.P. MORGAN VENTURES CORP

  • 10% Owner
No longer subject to file 2008-10-09 0

AIGNER STEFAN

  • FMR EVP/CORPORATE DEVELOPMENT
No longer subject to file 2008-08-22 0

CARLSSON CARL AKE PRESIDENT, API

  • Officer
No longer subject to file 2008-04-01 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments